Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Birol Emir

Showing results (71-80 of 110) with videos related to

Pageof 11
Sort By:
Pragmatic and Observational Research|December 6, 2019
Integrating Machine Learning With Microsimulation to Classify Hypothetical, Novel Patients for Predicting Pregabalin Treatment Response Based on Observational and Randomized Data in Patients With Painful Diabetic Peripheral NeuropathyJoe Alexander, Roger A Edwards, Luigi Manca, et al.
BMC Medical Research Methodology|July 22, 2017
Integrating data from randomized controlled trials and observational studies to predict the response to pregabalin in patients with painful diabetic peripheral neuropathyJoe Alexander, Roger A Edwards, Alberto Savoldelli, et al.
Epilepsia|March 30, 2010
Long-term add-on pregabalin treatment in patients with partial-onset epilepsy: pooled analysis of open-label clinical trialsBasim M Uthman, Carl W Bazil, Ahmad Beydoun, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|April 7, 2018
USE OF ELECTRONIC HEALTH RECORDS TO CHARACTERIZE A RARE DISEASE IN THE U.S.: TREATMENT, COMORBIDITIES, AND FOLLOW-UP TRENDS AMONG PATIENTS WITH A CONFIRMED DIAGNOSIS OF ACROMEGALYJulie M Silverstein, Erin D Roe, Kashif M Munir, et al.
Thrombosis and Haemostasis|December 28, 2021
Effectiveness and Safety of Apixaban versus Warfarin in Venous Thromboembolism Patients with Chronic Kidney DiseaseAlexander T Cohen, Janvi Sah, Amol D Dhamane, et al.
Journal of Occupational and Environmental Medicine|March 28, 2023
Quantifying The Burden of Persistent Musculoskeletal Pain in Employees at Rolls-Royce in The United Kingdom: A Real-World Cross-Sectional SurveyLucy Abraham, Rachel Russell, Lidia Sanchez-Riera, et al.
Advances in Therapy|September 27, 2021
Effectiveness and Safety of Apixaban Versus Warfarin Among Older Patients with Venous Thromboembolism with Different Demographics and Socioeconomic StatusAlexander T Cohen, Janvi Sah, Amol D Dhamane, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|September 11, 2023
An interrupted time series study of electronic health record clinical decision support for providers caring for patients with atrial fibrillation at increased stroke riskAndrew J Osterland, Marie Yasuda, Robert J Widmer, et al.
Plos One|September 23, 2022
Effectiveness and safety of apixaban vs warfarin among venous thromboembolism patients at high-risk of bleedingAlexander T Cohen, Janvi Sah, Amol D Dhamane, et al.
Journal of Health Economics and Outcomes Research|September 5, 2022
Risk Factors Associated with Falls and Fractures Following Prescription of Opioids Among Privately Insured Patients with OsteoarthritisStuart Silverman, Patricia Schepman, J Bradford Rice, et al.
Pageof 11

Showing results (71-80 of 110) with videos related to

Sort By:
Pageof 11
Pragmatic and Observational Research|December 6, 2019
Integrating Machine Learning With Microsimulation to Classify Hypothetical, Novel Patients for Predicting Pregabalin Treatment Response Based on Observational and Randomized Data in Patients With Painful Diabetic Peripheral NeuropathyJoe Alexander, Roger A Edwards, Luigi Manca, et al.
BMC Medical Research Methodology|July 22, 2017
Integrating data from randomized controlled trials and observational studies to predict the response to pregabalin in patients with painful diabetic peripheral neuropathyJoe Alexander, Roger A Edwards, Alberto Savoldelli, et al.
Epilepsia|March 30, 2010
Long-term add-on pregabalin treatment in patients with partial-onset epilepsy: pooled analysis of open-label clinical trialsBasim M Uthman, Carl W Bazil, Ahmad Beydoun, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|April 7, 2018
USE OF ELECTRONIC HEALTH RECORDS TO CHARACTERIZE A RARE DISEASE IN THE U.S.: TREATMENT, COMORBIDITIES, AND FOLLOW-UP TRENDS AMONG PATIENTS WITH A CONFIRMED DIAGNOSIS OF ACROMEGALYJulie M Silverstein, Erin D Roe, Kashif M Munir, et al.
Thrombosis and Haemostasis|December 28, 2021
Effectiveness and Safety of Apixaban versus Warfarin in Venous Thromboembolism Patients with Chronic Kidney DiseaseAlexander T Cohen, Janvi Sah, Amol D Dhamane, et al.
Journal of Occupational and Environmental Medicine|March 28, 2023
Quantifying The Burden of Persistent Musculoskeletal Pain in Employees at Rolls-Royce in The United Kingdom: A Real-World Cross-Sectional SurveyLucy Abraham, Rachel Russell, Lidia Sanchez-Riera, et al.
Advances in Therapy|September 27, 2021
Effectiveness and Safety of Apixaban Versus Warfarin Among Older Patients with Venous Thromboembolism with Different Demographics and Socioeconomic StatusAlexander T Cohen, Janvi Sah, Amol D Dhamane, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|September 11, 2023
An interrupted time series study of electronic health record clinical decision support for providers caring for patients with atrial fibrillation at increased stroke riskAndrew J Osterland, Marie Yasuda, Robert J Widmer, et al.
Plos One|September 23, 2022
Effectiveness and safety of apixaban vs warfarin among venous thromboembolism patients at high-risk of bleedingAlexander T Cohen, Janvi Sah, Amol D Dhamane, et al.
Journal of Health Economics and Outcomes Research|September 5, 2022
Risk Factors Associated with Falls and Fractures Following Prescription of Opioids Among Privately Insured Patients with OsteoarthritisStuart Silverman, Patricia Schepman, J Bradford Rice, et al.
Pageof 11